Figure 10 | Scientific Reports

Figure 10

From: Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy

Figure 10

2D interactions of hit compounds with KRASG12D binding site residues. Snapshots depicts interactions at 100 ns, 200 ns, 300 ns and 450 ns. (A) Shows ZINC78453217 interactions with the binding site residues. (A1) Shows ZINC70875226 interaction with the binding site residues. (A2) Shows ZINC64890902 interactions with the binding site interactions.

Back to article page